Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Consulting agrmnt
Quarterly results
Appointed director
Stock private placement
Asset disposition
Acq. announced
TearLab Corp (TEAR) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/08/2019 8-K Quarterly results
Docs: "TearLab Corporation Reports Third Quarter 2019 Financial Results"
05/09/2019 8-K Quarterly results
Docs: "TearLab Corporation Reports First Quarter 2019 Financial Results"
08/09/2018 8-K Quarterly results
Docs: "TearLab Corporation Reports Second Quarter and First Half 2018 Financial Results SAN DIEGO, Aug 9, 2018 — TearLab Corporation today reported its consolidated financial results for the second quarter ended June 30, 2018. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles except where noted otherwise. Second Quarter and Recent Highlights - Second quarter revenue of $6.4 million, holding revenue flat over the first quarter of 2018 - Income from operations of $0.5 million, compared to operating loss of $2.8 million in second quarter 2017 - Expanded the U.S. active device base to 4,761 TearLab Osmolarity Systems - On track for resubmission and U.S. Food and Drug Administration response to 510 fili..."
11/13/2017 8-K Quarterly results
Docs: "TearLab Corporation Reports Third Quarter and September Year-To-Date 2017 Financial Results SAN DIEGO, November 13, 2017 — TearLab Corporation today reported its consolidated financial results for the third quarter and nine months ended September 30, 2017. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles except where noted otherwise. Third Quarter 2017 and Recent Operational Highlights - Announced updated U.S. regulatory strategy for TearLab Discovery™ System; Company remains on-track to submit 510 application to FDA by year-end - Expanded the active U.S. user base of TearLab Osmolarity Systems in key programs by 74 units to 4,522 devices - Further reduction in operating expenses; ope..."
08/14/2017 8-K Quarterly results
05/15/2017 8-K Form 8-K - Current report
03/09/2017 8-K Form 8-K - Current report
11/07/2016 8-K Quarterly results
Docs: "TearLab Corporation Reports Third Quarter and September Year-To-Date 2016 Financial Results"
08/03/2016 8-K Form 8-K - Current report
05/04/2016 8-K Form 8-K - Current report
11/05/2015 8-K Quarterly results
Docs: "TearLab Corporation Reports Q3-15 Financial Results"
08/06/2015 8-K Quarterly results
Docs: "TearLab Corporation Reports Q2-15 Financial Results"
05/11/2015 8-K Quarterly results
Docs: "TearLab Corporation Reports Q1-15 Financial Results"
11/06/2014 8-K Quarterly results
Docs: "TearLab Corporation Reports Q3-14 Financial Results"
08/07/2014 8-K Quarterly results
Docs: "TearLab Corporation Reports Q2-14 Financial Results and Adjusts 2014 Revenue Guidance"
08/14/2013 8-K/A Quarterly results
Docs: "TearLab Corporation Reports Q2-13 Financial Results"
05/14/2013 8-K Quarterly results
Docs: "TearLab Corporation Reports Q1-13 Financial Results"
11/13/2012 8-K Form 8-K - Current report
08/08/2012 8-K Quarterly results
Docs: "TearLab Corporation Reports Q2-12 Financial Results"
05/15/2012 8-K Form 8-K - Current report
03/23/2012 8-K Form 8-K - Current report
11/10/2011 8-K Form 8-K - Current report
08/10/2011 8-K Form 8-K - Current report
05/11/2011 8-K Quarterly results
Docs: "TearLab Corporation, Reports Q1-11 Financial Results"
03/28/2011 8-K Form 8-K - Current report
11/06/2006 8-K Form 8-K - Current report

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy